Cite
Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia
MLA
Ohnishi T, et al. “Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia.” Neuropsychiatric Disease and Treatment, vol. ume 17, Apr. 2021, pp. 1095–104. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.84d177e2918d459cb0f96654651b1332&authtype=sso&custid=ns315887.
APA
Ohnishi T, Wakamatsu A, & Kobayashi H. (2021). Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia. Neuropsychiatric Disease and Treatment, ume 17, 1095–1104.
Chicago
Ohnishi T, Wakamatsu A, and Kobayashi H. 2021. “Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia.” Neuropsychiatric Disease and Treatment ume 17 (April): 1095–1104. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.84d177e2918d459cb0f96654651b1332&authtype=sso&custid=ns315887.